Product identification
Medicine name:
Rabisin Glikoproteiny wirusa wścieklizny nie mniej niż 1IU Zawiesina do wstrzykiwań
Active substance:
- Rabies virus, Inactivated
Target species:
-
Cattle
-
Sheep
-
Horse
-
Cat
-
Ferret
-
Dog
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Rabies virus, Inactivated1.00international unit(s)1.00international unit(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
All relevant tissues0day
-
-
Sheep
-
All relevant tissues0day
-
-
Horse
-
All relevant tissues0day
-
-
Cat
-
Ferret
-
All relevant tissues0day
-
-
Dog
-
-
Intramuscular use
-
Cattle
-
All relevant tissues0day
-
-
Sheep
-
All relevant tissues0day
-
-
Horse
-
All relevant tissues0day
-
-
Cat
-
Ferret
-
All relevant tissues0day
-
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02X
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Available in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France SCS
Authorisation number:
- 0537
Date of authorisation status change:
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022